Clinical Trial Update: Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating durvalumab after chemo-radiation in microsatellite-stable stage II-IV rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED